|
| 35074532 | Performance of Noninvasive Tests of Fibrosis Among Asians, Hispanic, and non-Hispanic Whites in the STELLAR Trials. | Clin Gastroenterol Hepatol | 2023 |
| 37895312 | Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma. | Genes (Basel) | 2023 |
| 37424500 | Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study. | Korean J Intern Med | 2023 |
| 37069419 | Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease. | Hepatol Int | 2023 |
| 36375797 | ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis. | Clin Gastroenterol Hepatol | 2023 |
| 34091048 | Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B. | Clin Gastroenterol Hepatol | 2022 |
| 35741307 | A Case of Hepatic Immunoglobulin G4-Related Disease Presenting as an Inflammatory Pseudotumor and Sclerosing Cholangitis. | Diagnostics (Basel) | 2022 |
| 36140656 | Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19. | Diagnostics (Basel) | 2022 |
| 35867702 | Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial. | PLoS One | 2022 |
| 36011395 | Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma. | Genes (Basel) | 2022 |
| 35054267 | Deep Learning-Based Four-Region Lung Segmentation in Chest Radiography for COVID-19 Diagnosis. | Diagnostics (Basel) | 2022 |
| 34478195 | Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B. | J Gastroenterol Hepatol | 2022 |
| 32856240 | Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study. | Dig Dis Sci | 2021 |
| 33879706 | Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma. | Medicine (Baltimore) | 2021 |
| 33904261 | Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients. | J Korean Med Sci | 2021 |
| 33711739 | Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19. | Med Image Anal | 2021 |
| 33846041 | A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records. | Eur J Radiol | 2021 |
| 33782216 | Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment. | Gut Liver | 2021 |
| 33810942 | The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma. | Eur J Intern Med | 2021 |
| 34526699 | Federated learning for predicting clinical outcomes in patients with COVID-19. | Nat Med | 2021 |
| 34207587 | Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver. | Diagnostics (Basel) | 2021 |
| 34166456 | Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites. | PLoS One | 2021 |
| 33029863 | Validation of risk prediction scores for hepatocellular carcinoma in patients with chronic hepatitis B treated with entecavir or tenofovir. | J Viral Hepat | 2021 |
| 33303715 | Diagnostic Efficacy of Serum Mac-2 Binding Protein Glycosylation Isomer and Other Markers for Liver Fibrosis in Non-Alcoholic Fatty Liver Diseases. | Ann Lab Med | 2021 |
| 33442676 | Federated Learning used for predicting outcomes in SARS-COV-2 patients. | Res Sq | 2021 |
| 33381930 | Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma. | Yonsei Med J | 2021 |
| 31252188 | Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy. | Clin Gastroenterol Hepatol | 2020 |
| 31816673 | Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma. | Gut Liver | 2020 |
| 32087795 | Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study. | Lancet Gastroenterol Hepatol | 2020 |
| 31988073 | Hepatocellular Carcinoma Risk Steadily Persists over Time Despite Long-Term Antiviral Therapy for Hepatitis B: A Multicenter Study. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32071913 | Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma. | Liver Cancer | 2020 |
| 33114104 | Examining Liver Cancer Patients and a High-Risk Group in a Vulnerable Area: An Experience from the Ulleung Liver Cancer Prevention and Management Project. | Int J Environ Res Public Health | 2020 |
| 33053932 | Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea. | Clin Mol Hepatol | 2020 |
| 33304943 | Percutaneous portal vein embolization for intractable hepatic biloma after radiofrequency ablation. | Eur J Radiol Open | 2020 |
| 33184086 | Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study. | BMJ Open | 2020 |
| 33044938 | Severity and Consolidation Quantification of COVID-19 From CT Images Using Deep Learning Based on Hybrid Weak Labels. | IEEE J Biomed Health Inform | 2020 |
| 32715667 | Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea. | J Korean Med Sci | 2020 |
| 32852880 | A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy. | J Viral Hepat | 2020 |
| 33022942 | Plasma Long Noncoding RNA <i>LeXis</i> is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis. | Life (Basel) | 2020 |
| 32413995 | Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. | Genes (Basel) | 2020 |
| 32383246 | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir. | J Viral Hepat | 2020 |
| 32460460 | Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response. | Clin Mol Hepatol | 2020 |
| 32429077 | Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study. | Nutrients | 2020 |
| 32452564 | Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase. | Aliment Pharmacol Ther | 2020 |
| 29792020 | Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world. | Korean J Intern Med | 2019 |
| 30194739 | A Model to Predict 1-Month Risk of Transplant or Death in Hepatitis A-Related Acute Liver Failure. | Hepatology | 2019 |
| 30731195 | Long-term Outcomes of Antiviral Therapy in Patients With Advanced Chronic HBV Infection. | Clin Gastroenterol Hepatol | 2019 |
| 30959156 | A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea. | J Hepatol | 2019 |
| 31132846 | An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection. | Clin Mol Hepatol | 2019 |
| 30324553 | Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis. | Dig Dis Sci | 2019 |